SSY Group (HK:2005) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SSY Group Limited has received approval from China’s National Medical Products Administration for the production of its Compound Sodium Acetate and Glucose Injection, which is used for replenishing water and electrolytes. This development positions SSY Group among the first three manufacturers in China to be approved for this type of drug production, signaling a promising advancement in their pharmaceutical offerings.
For further insights into HK:2005 stock, check out TipRanks’ Stock Analysis page.